Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Boston US life science company Cerevance, which has facilities at Cambridge Science Park, has taken its Series B-1 round to a stunning $98 million after securing a $47m extension.
Kindly share this postZipline, the leading force in drone logistics delivery, has reached a monumental achievement with its one-millionth delivery to customers, signifying a significant leap forward in the logistics delivery sector. This historic milestone was marked by the delivery of two bags of IV fluid from a Zipline distribution center in Ghana to a […]